SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001126234-21-000086
Filing Date
2021-05-28
Accepted
2021-05-28 19:03:16
Documents
2
Period of Report
2021-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162224298088195.html 3  
1 FORM 3 wf-form3_162224298088195.xml 3 5902
2 SCHUCHART POA ex-24.htm EX-24 4384
  Complete submission text file 0001126234-21-000086.txt   11795
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S.MOPAC EXPWY,BARTONOAKSPLAZONE,#250 AUSTIN TX 78746
Business Address
Schuchart Aaron (Reporting) CIK: 0001709258 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35342 | Film No.: 21982269